Methods of producing anamorelin hydrochloride having controlled chloride content

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9872883
APP PUB NO 20160235804A1
SERIAL NO

15135147

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to particulate forms of anamorelin monohydrochloride or a composition comprising anamorelin monohydrochloride having controlled chloride content, preferably isolated in an amorphous and/or fine particulate state, processes for making the particulate forms, and pharmaceutical compositions comprising the particulate forms.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ONO PHARMACEUTICAL CO LTD1-5 DOSHO-MACHI 2-CHOME CHUO-KU OSAKA-SHI OSAKA 541-8526
HELSINN HEALTHCARE S ALUGANO SWITZERLAND \/ BAZZERO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
De, Groot Eleanor Houston, US 9 34
Garcia, Rubio Silvina Princeton, US 20 45
Kuwabe, Shin-itsu Osaka, JP 9 37
Manini, Peter Giubiasco, CH 27 431
Pines, Seemon Newton, US 10 71
Yanagimachi, Takehiko Osaka, JP 8 34
Yoshiyama, Hideyuki Osaka, JP 11 54

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 23, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 23, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00